WVE News and Press, Wave Life Sciences Ltd. From 05/09/24

2024-05-09 14:53:01 ET Wave Life Sciences Ltd. (WVE) Q1 2024 Earnings Conference Call May 09, 2024 08:30 AM ET Company Participants Kate Rausch - Vice President, Investor Relations & Corporate Affairs Paul Bolno - President & Chief Executive Officer Anne-...

2024-05-09 07:41:48 ET More on Wave Life Sciences Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche Seeking Alpha’s Quant Rating on Wave Life Sciences Read the full article on Seeking Alpha For further details see: Wave Life Sciences ...

RestorAATion-2 clinical trial of WVE-006 in AATD patients underway; expected proof-of-mechanism data in patients with AATD remains on track for 2024 INHBE program for obesity expected clinical trial initiation in 1Q 2025; preclinical data demonstrate weight loss similar to semaglutide, ...

2024-05-09 07:11:34 ET More on Wave Life Sciences Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche Read the full article on Seeking Alpha For further details see: Wave Life Sciences names Erik Ingelsson as chief scientific officer

CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the appointment of Erik Ingelsson, MD, PhD, as Chief Scientific Off...

2024-05-08 14:05:55 ET More on Wave Life Sciences Wave Life Sciences' Weighty Ambition: Carving Out Obesity Niche Wave Life Sciences Ltd. (WVE) Q4 2023 Earnings Call Transcript Wave Life Sciences Q4 2023 Earnings Preview Seeking Alpha’s Quant Rating on...

CAMBRIDGE, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Paul Bolno, MD, MBA, President and Chief Executive Officer, is...

CAMBRIDGE, Mass., May 02, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, May 9, 20...

CAMBRIDGE, Mass., April 30, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced the approval of its first clinical trial application (CTA) for it...

2024-04-23 10:29:06 ET More on Edgewise Therapeutics Edgewise Therapeutics: Behind The Massive Rally Krystal Biotech, Candel, Edgewise gain after FDA fast track tags Seeking Alpha’s Quant Rating on Edgewise Therapeutics Historical earnings data for Edg...